ERBB2 and breast carcinoma: Remarkably, knockdown of Chd4 significantly reduced MMTV-NeuT cell growth (45%) and cell migration (46%) compared to the control (Figure 3B, 3C), confirming that CHD4 is implicated in the development of HER2+ breast cancer, independently of the immunological context.